NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. (NBSE) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 39 transactions totaling $1.3M, demonstrating a bearish sentiment with -$163.6K in net insider flow. The most recent transaction on Sep 18, 2023 involved a sale of 50,000 shares valued at $59.5K.
NBSE Insider Activity Summary
Who Is Buying NBSE Stock?
No significant insider buying has been recorded for NBSE in the recent period.
Who Is Selling NBSE Stock?
No significant insider selling has been recorded for NBSE in the recent period.
Is NeuBase Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NBSE is bearish with an Insider Alignment Score of 44/100 and a net flow of -$163.6K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
NBSE Frequently Asked Questions
Understanding NBSE Insider Activity
Insider trading at NeuBase Therapeutics, Inc. (NBSE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading NBSE stock, having executed 39 transactions in the past 90 days. The most active insider is Corp Symetryx (Executive), who has made 7 transactions totaling $772.2K.
Related Tools
Track NeuBase Therapeutics, Inc. Insider Activity
Get notified when executives and directors at NBSE file new Form 4 transactions